137 related articles for article (PubMed ID: 4271546)
21. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
22. Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphine.
Buczko W; Wiśniewski K
Thromb Diath Haemorrh; 1972 Dec; 28(3):359-66. PubMed ID: 4265317
[No Abstract] [Full Text] [Related]
23. Fibrin degradation products. A review of structures found in vitro and in vivo.
Gaffney PJ
Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
[TBL] [Abstract][Full Text] [Related]
24. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
25. [Action of anti-plasmin in activation of the fibrinolysis system and its clinical management].
Tabara C; Hitano E; Mizuno Y; Kazama M; Abe H
Rinsho Byori; 1974 Oct; 22(10 Suppl):105. PubMed ID: 4281036
[No Abstract] [Full Text] [Related]
26. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
27. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
28. A rapid method for the semiquantitative determination of fibrinogen and fibrinogen degradation products (FDP) in defibrination syndrome.
Sas G; Jákó J; Domán J; László C; Pádár J
Thromb Diath Haemorrh; 1971 Jun; 25(3):555-65. PubMed ID: 4254505
[No Abstract] [Full Text] [Related]
29. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
Catanzaro A; Edgington TS
J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
[No Abstract] [Full Text] [Related]
30. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
Beller FK; Maki M
Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
[No Abstract] [Full Text] [Related]
31. Plasmin potency estimates: influence of the substrate used in assay.
Philo RD; Gaffney PJ
Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
[TBL] [Abstract][Full Text] [Related]
32. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.
Smith RA; Dupe RJ; English PD; Green J
Thromb Haemost; 1982 Jun; 47(3):269-74. PubMed ID: 6214039
[TBL] [Abstract][Full Text] [Related]
33. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
Soria J; Soria C; Vairel E; Prost RJ; Warneson G
Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
[No Abstract] [Full Text] [Related]
34. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
Konttinen YP; Kemppainen L; Turunen O
Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
[No Abstract] [Full Text] [Related]
36. Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54).
Arefieva TL; Krasnikova TL
J Cell Physiol; 2001 Sep; 188(3):403-9. PubMed ID: 11473367
[TBL] [Abstract][Full Text] [Related]
37. [Effect of blood serum antiplasmin and euglobulins on fibrinolysis and fibrinogenolysis in vitro].
Bratus' GM; Gorodetskiĭ AL; Byshevskiĭ ASh
Vopr Med Khim; 1971; 17(5):547-9. PubMed ID: 4256467
[No Abstract] [Full Text] [Related]
38. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
Loly W; Israels LG; Bishop AJ; Israels ED
Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
[No Abstract] [Full Text] [Related]
39. Unknown properties of the products of plasmin-degradation of fibrinogen and fibrin.
Buluk K; Malofiejew M; Czokalo M
Bull Acad Pol Sci Biol; 1966; 14(4):193-7. PubMed ID: 4223765
[No Abstract] [Full Text] [Related]
40. Some aspects of fibrinogen biochemistry: interaction with proteolytic enzymes.
Donati MB
Acta Vitaminol Enzymol; 1973; 27(5):233-41. PubMed ID: 4274938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
